Ribbon Acquisition Corp. Reports Q2 2025 Financial Results and Business Combination Agreement

Ribbon Acquisition Corp. has reported its financial results for the second quarter of 2025, revealing a net income of $271,297 for the three months ending June 30, 2025, compared to a net income of $235,856 for the previous quarter. The company’s total operating expenses for the quarter were $242,894, leading to a loss from operations of $242,894. For the first half of 2025, Ribbon reported a net income of $507,153, with total operating expenses amounting to $428,295. The income earned on marketable securities held in the Trust Account contributed significantly to the net income, totaling $514,191 for the quarter and $935,448 for the six-month period.

The company’s balance sheet as of June 30, 2025, shows total assets of $51,287,084, a substantial increase from $508,662 at the end of 2024. This increase is primarily due to the successful completion of its Initial Public Offering (IPO) on January 16, 2025, which raised $50 million in gross proceeds. The IPO involved the sale of 5,000,000 units at $10.00 each, and the company also completed a private placement of 220,000 units, generating an additional $2.2 million. As a result, cash and marketable securities held in the Trust Account amounted to $50,935,456 as of the end of the reporting period.

In terms of operational developments, Ribbon Acquisition Corp. has not yet commenced any business operations, as it is a blank check company focused on identifying a target for a business combination. The company has until January 16, 2026, to complete its initial business combination, or it will face liquidation. As of June 30, 2025, the company had 5,000,000 Class A ordinary shares subject to possible redemption, valued at $46,672,612. The company’s management has indicated that it is actively pursuing potential business combinations and is incurring costs associated with these efforts.

Looking ahead, Ribbon Acquisition Corp. has entered into a Business Combination Agreement with DRC Medicine Inc. and DRC Medicine Ltd., which is expected to facilitate a merger and the establishment of a new corporate structure. The company plans to migrate from the Cayman Islands to Delaware as part of this transaction. The merger consideration will be determined based on the equity value and redemption price of the Class A ordinary shares. Ribbon's management remains optimistic about completing the business combination, although it acknowledges the inherent risks and uncertainties involved in the process.